Pfizer Stock News

Bonds Bloodbath, Dollar Dumped As Omicron Anxiety Ebbs & Flows Anxiety over Omicron was higher overnight from South African data showing Pfizer vaxx efficacy weakened against Omicron but then the CEO of the company that makes billions from the vaccine - and is protected from any liabilities - said, all you need is a 3rd jab and that will save you all from Omicron... and the market rejoiced. Small Caps outperformed today but traded in a truly chaotic manner. The Dow ended the day unchanged-ish and S&P and Nasdaq modestly higher... Notably, the major US equity indices remain unable to extend gains above pre-Omicron levels... ''Recovery'' stocks continue to charge higher relative to ''Stay at Home'' stocks... Source: Bloomberg Despite all the jawboning, Pfizer, BioNtech and Moderna are all down on the week... Source: Bloomberg Bond yields exploded higher today (amid a very heavy calendar). 30Y Yields are up 20bps this week while 2Y is only up 8bps... Source: Bloomberg 30Y Yields remain well below 2.00% (pre-Omicron) levels, but today was a decent squeeze to say the least as 30Y spiked over 13bps from low to high yield...

Major stock markets in the United States closed higher on Wednesday after the newest report showed a rise in job openings to 11 million. Meanwhile, President Joe Biden stated that Pfizer Inc. and BioN

The booster protects, and two shots may not be enough.

Related Stocks: HCA , BIO.B , PFE , PKI , TDY , HOLX , IDXX , MNST , EPC , UVV , HSIC , TECH , PRMW , BTI ,

Pfizer Inc. Chief Executive Officer (CEO) Albert Bourla expressed on Wednesday his expectations the necessity of the fourth dose of vaccines against COVID-19 is likely to emerge sooner than expected.

The Food and Drug Administration is asking for 75 years twenty years more than it originally agreed in order to []

The approval came hours after Pfizer issued a statement saying preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech Covid-19 vaccine neutralise the Omicron variant.

Pfizer said that a booster dose of their vaccine neutralized the Omicron variant in lab testing, but that the two-dose regimen was significantly less effective. A third dose increased antibodies 25 times compared to the two doses, the Wall Street Journal reports. Still, two doses may be effective in preventing severe symptoms because immune cells [] The post STUDY: Pfizer Vaccine Loses Significant Effectiveness Against Omicron appeared first on Human Events .

"Absolutely Appalling": Mother Says LA School Vaccinated Son Without Consent, Bribed With Pizza A Los Angeles school has been accused of vaccinating a 13-year-old boy without his mother''s consent . Maribel Duarte told KNBC-TV that her son was bribed with pizza and told not to tell her about it by an official at the Barack Obama Global Prep Academy in South Los Angeles. "The lady that gave him the shot and signed the paper told my son, ''Please don''t say anything. I don''t want to get in trouble,''" said Duarte, who showed the outlet a vaccine card indicating that her son accepted it. It indicates that two doses of Pfizer''s vaccine was administered, one on Oct. 28, and the other on Nov. 18. Image source: KNBC-TV video screenshot via The Blaze Duarte says she''s not anti-vax and is vaccinated herself, but that her son is a special case. "He has problems with asthma and allergy problems," she said, adding: "It hurt to know he got a shot without my permission, without knowing and without signing any papers for him to get the shot. " Absolutely appalling.

Pfizer said a booster of its Covid-19 vaccine may offer important protection against the new Omicron variant even though the initial two doses appear significantly less effective. Pfizer and its partner

BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver a vaccine targeted at it in March 2022 if needed. Francis Maguire reports.

BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and said they could deliver an upgraded vaccine in March 2022 if needed.

President Biden said he was glad to see Pfizer''s report that a third dose of its COVID-19 vaccine works against the Omicron variant.

A study shows that Pfizer''s booster restored antibodies to levels observed in people with two doses against the original coronavirus strain.

Two Pfizer/BioNTech Covid vaccines might not be sufficient to protect against infection, but according to preliminary studies three doses neutralises Omicron. Two vaccines will still work against severe disease as The post Three doses of Pfizer vaccine neutralises Omicron, but two may not be sufficient to protect against infection appeared first on London Business News | Londonlovesbusiness.com .